Integer Holdings (Integer Holdings) Change In Working Capital : $-43 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings Change In Working Capital?

Integer Holdings's change in working capital for the quarter that ended in Mar. 2024 was $-34 Mil.

Integer Holdings's change in working capital for the fiscal year that ended in Dec. 2023 was $-52 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Integer Holdings Change In Working Capital Historical Data

The historical data trend for Integer Holdings's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings Change In Working Capital Chart

Integer Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-40.13

16.16

-47.75

-75.85

-52.30

Integer Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-43.46	-1.32	-2.56	-4.96	-34.25

Integer Holdings Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-43 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Integer Holdings Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Integer Holdings (Integer Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

WGB:Germany

Address

5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024

Website

https://www.integer.net

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.

Executives

Donald J Spence	director	C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jean M. Hobby	director	10000 WEHRLE DRIVE, CLARENCE NY 14031
Jim Stephens	officer: President, CRM & Neuro	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith	officer: VP, Interim CFO	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic	director	1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey	director	1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton	officer: President, Electrochem	10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn	officer: SVP, Strategy and Business Dev	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Marshall Mcalister C Ii	officer: SVP, Gen Counsel & Secretary	1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226
Margaret Carthy	officer: SVP, Quality & Regulatory Affa	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph F Flanagan	officer: EVP, Quality & Regulatory Affa	10000 WEHRLE DRIVE, CLARENCE NY 14031
Bill R Sanford	director	2617 BULRUSH LANE, NAPLES FL 34105
Anthony W Borowicz	officer: SVP Strategy,Corp Dev., IR	10000 WEHRLE DRIVE, CLARENCE NY 14031
Sheila Antrum	director	5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024